Stephanie Hines, MD, of the breast clinic at the Mayo Clinic in Jacksonville, Fla., also has started offering exemestane for primary prevention. "From my experience, women are more open to taking exemestane because of the greater risk reduction that was reported," she said in an email to MedPage Today. "The side-effect profile is also more acceptable to women, since there is no evidence of an increased risk of uterine cancers and thromboemobolic disease is not reported."

MedPage Today, 12/2011

Tags: Breast Cancer, Cancer, Mayo Clinic Jacksonville